1-20 of 24
E. Martinez
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric Cancer

P. Jake Slavish, Liying Chi, Mi-Kyung Yun, Lyudmila Tsurkan, Nancy E. Martinez, Barbara Jonchere, Sergio C. Chai, Michele Connelly, M. Brett Waddell, Sourav Das, Geoffrey Neale, Zhenmei Li, William R. Shadrick, Rachelle R. Olsen, Kevin W. Freeman, Jonathan A. Low, Jeanine E. Price, Brandon M. Young, Nagakumar Bharatham, Vincent A. Boyd, Jun Yang, Richard E. Lee, Marie Morfouace, Martine F. Roussel, Taosheng Chen, Daniel Savic, R. Kiplin Guy, Stephen W. White, Anang A. Shelat, Philip M. Potter
Journal: Cancer Research
Cancer Res (2020) 80 (17): 3507–3518.
https://doi.org/10.1158/0008-5472.CAN-19-3934
Published: 02 September 2020
View articletitled, Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric Cancer
Open the PDF for Bromodomain-Selective BET Inhibitors Are Potent Antitumor Agents against MYC-Driven Pediatric Cancer in another window
Includes: Supplementary data
Journal Articles

Abstract 4293: Final result of lenvatinib and capecitabine in combination with external beam radiation in treatment of locally advanced rectal cancer: Phase I clinical trial

Ankita Tandon, Jessica M. Frakes, Rutika Mehta, Sarah Hoffe, Iman Imanirad, Maria E. Martinez Jimenez, Julian Sanchez, Mokenge Malafa, Seth Felder, Sophie Dessureault, Richard D. Kim
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 4293.
https://doi.org/10.1158/1538-7445.AM2020-4293
Published: 15 August 2020
View articletitled, Abstract 4293: Final result of lenvatinib and capecitabine in combination with external beam radiation in treatment of locally advanced rectal cancer: Phase I clinical trial
Journal Articles

Abstract LB-089: Targeting transferrin receptor 1 (TfR1) with the ch128.1/IgG1 antibody inhibits Epstein-Barr virus (EBV) driven lymphoproliferative growth and lymphomagenesis in immunosuppressed mice bearing human B cells

Laura E. Martinez, Tracy R. Daniels-Wells, Yu Guo, Larry I. Magpantay, Pierre V. Candelaria, Manuel L. Penichet, Otoniel Martinez-Maza, Marta Epeldegui
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): LB-089.
https://doi.org/10.1158/1538-7445.AM2020-LB-089
Published: 15 August 2020
View articletitled, Abstract LB-089: Targeting transferrin receptor 1 (TfR1) with the ch128.1/IgG1 antibody inhibits Epstein-Barr virus (EBV) driven lymphoproliferative growth and lymphomagenesis in immunosuppressed mice bearing human B cells
Journal Articles

Abstract 4621: Polymorphisms in JAK/STAT signaling pathway genes and risk of breast cancer

Manuela Gago-Dominguez, Maria E. Martinez, Roger Milne, Marcos Matabuena, Carmen Redondo, José Esteban Castelao, Catriona Jamieson
Journal: Cancer Research
Cancer Res (2020) 80 (16_Supplement): 4621.
https://doi.org/10.1158/1538-7445.AM2020-4621
Published: 15 August 2020
View articletitled, Abstract 4621: Polymorphisms in JAK/STAT signaling pathway genes and risk of breast cancer
Journal Articles

Abstract 4358: Characterization of primary and metastatic pancreatic tumors in pancreatic ductal adenocarcinoma (PDAC)

Andrés E. Martínez-Muñiz, Sharanya Sivanand, Matthew Vander Heiden
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): 4358.
https://doi.org/10.1158/1538-7445.AM2019-4358
Published: 01 July 2019
View articletitled, Abstract 4358: Characterization of primary and metastatic pancreatic tumors in pancreatic ductal adenocarcinoma (PDAC)
Journal Articles

Abstract GS2-04: Efficacy results from CIBOMA/2004-01_GEICAM/2003-11 study: A randomized phase III trial assessing adjuvant capecitabine after standard chemotherapy for patients with early triple negative breast cancer

M Martín, CH Barrios, L Torrecillas, M Ruiz-Borrego, J Bines, J Segalla, A Ruiz, JA García-Sáenz, R Torres, J de la Haba, E García, HL Gómez, A Llombart, M Rodríguez de la Borbolla, JM Baena, A Barnadas, L Calvo, L Pérez-Michel, M Ramos, J Castellanos, A Rodríguez-Lescure, J Cárdenas, J Vinholes, E Martínez de Dueñas, MJ Godes, MA Seguí, A Antón, P López-Álvarez, J Moncayo, G Amorim, E Villar, S Reyes, C Sampaio, B Cardemil, MJ Escudero, S Bezares, E Carrasco, A Lluch
Journal: Cancer Research
Cancer Res (2019) 79 (4_Supplement): GS2-04.
https://doi.org/10.1158/1538-7445.SABCS18-GS2-04
Published: 15 February 2019
View articletitled, Abstract GS2-04: Efficacy results from CIBOMA/2004-01_GEICAM/2003-11 study: A randomized phase III trial assessing adjuvant capecitabine after standard chemotherapy for patients with early triple negative breast cancer
Journal Articles

Abstract PD3-03: SOLTI-1303 PATRICIA phase II trial (STAGE 1) -- Palbociclib and trastuzumab in postmenopausal patients with HER2-positive metastatic breast cancer

E Ciruelos, P Villagrasa, L Paré, M Oliveira, S Pernas, J Cortés, J Soberino, B Adamo, S Vazquez, N Martínez, A Perelló, B Bermejo, E Martínez, I Garau, M Melé, S Morales, P Galván, T Pascual, J Canes, P Nuciforo, X Gonzalez, A Prat
Journal: Cancer Research
Cancer Res (2019) 79 (4_Supplement): PD3-03.
https://doi.org/10.1158/1538-7445.SABCS18-PD3-03
Published: 15 February 2019
View articletitled, Abstract PD3-03: SOLTI-1303 PATRICIA phase II trial (STAGE 1) -- Palbociclib and trastuzumab in postmenopausal patients with HER2-positive metastatic breast cancer
Journal Articles

Abstract P6-17-07: Gene signatures and subtype changes during HER2 dual blockade in PAM50 HER2-enriched HER2-positive breast cancer

F Brasó-Maristany, G Griguolo, A Llombart-Cussac, T Pascual, L Paré, B Bermejo, M Oliveira, S Morales, N Martinez, M Vidal, S Pernas, R Lopez, M Muñoz, P Galvan, I Garau, L Manso, J Alarcón, E Martínez, P Villagrasa, J Cortés, A Prat
Journal: Cancer Research
Cancer Res (2019) 79 (4_Supplement): P6-17-07.
https://doi.org/10.1158/1538-7445.SABCS18-P6-17-07
Published: 15 February 2019
View articletitled, Abstract P6-17-07: Gene signatures and subtype changes during HER2 dual blockade in PAM50 HER2-enriched HER2-positive breast cancer
Journal Articles

Abstract P6-17-08: Dynamics of tumor-infiltrating lymphocytes (TILs) during neoadjuvant dual HER2 blockade in HER2-positive (HER2+) breast cancer in the absence of chemotherapy

G Griguolo, E Holgado, J Cortés, R Fasani, T Pascual, L Paré, B Bermejo, M Oliveira, S Morales, N Martinez, M Vidal, S Pernas, R Lopez, M Muñoz, P Galvan, I Garau, L Manso, J Alarcón, E Martínez, P Villagrasa, A LLombart-Cussac, A Prat, P Nuciforo
Journal: Cancer Research
Cancer Res (2019) 79 (4_Supplement): P6-17-08.
https://doi.org/10.1158/1538-7445.SABCS18-P6-17-08
Published: 15 February 2019
View articletitled, Abstract P6-17-08: Dynamics of tumor-infiltrating lymphocytes (TILs) during neoadjuvant dual HER2 blockade in HER2-positive (HER2+) breast cancer in the absence of chemotherapy
Journal Articles

Abstract PD9-04: FGFR4 as a key regulator of HER2E subtype in the primary and metastatic setting

S Garcia Recio, JS Parker, C Fan, K Mott, X He, JM Cejalvo, F Brasó Maristany, P Galván, A Lluch, J Albanell, F Rojo, E Martinez de Dueñas, A Prat, CM Perou
Journal: Cancer Research
Cancer Res (2019) 79 (4_Supplement): PD9-04.
https://doi.org/10.1158/1538-7445.SABCS18-PD9-04
Published: 15 February 2019
View articletitled, Abstract PD9-04: FGFR4 as a key regulator of HER2E subtype in the primary and metastatic setting
Journal Articles

Abstract 243: Genetic polymorphisms of diabetes-related genes, their interaction with diabetes status, and breast cancer incidence and mortality: The Long Island Breast Cancer Study Project

Humberto Parada, Rebecca J. Cleveland, Kari E. North, June Stevens, Susan L. Teitelbaum, Alfred I. Neugut, Regina M. Santella, Maria E. Martinez, Marilie D. Gammon
Journal: Cancer Research
Cancer Res (2018) 78 (13_Supplement): 243.
https://doi.org/10.1158/1538-7445.AM2018-243
Published: 01 July 2018
View articletitled, Abstract 243: Genetic polymorphisms of diabetes-related genes, their interaction with diabetes status, and breast cancer incidence and mortality: The Long Island Breast Cancer Study Project
Journal Articles

Abstract P2-09-14: A predictive model of pathological response following dual HER2 blockade-only based on tumor cellularity and tumor-infiltrating lymphocytes (CelTIL) in HER2-positive breast cancer

P Nuciforo, E Holgado, A Llombart, R Fasani, L Paré, T Pascual, M Oliveira, N Martínez, B Bermejo, M Vidal, S Pernas, R López, M Muñoz, I Garau, L Manso, J Alarcón, E Martínez, P Villagrasa, J Cortés, A Prat
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): P2-09-14.
https://doi.org/10.1158/1538-7445.SABCS17-P2-09-14
Published: 15 February 2018
View articletitled, Abstract P2-09-14: A predictive model of pathological response following dual HER2 blockade-only based on tumor cellularity and tumor-infiltrating lymphocytes (CelTIL) in HER2-positive breast cancer
Journal Articles

Abstract P5-20-19: PAM50 intrinsic subtype predicts survival outcome in HER2-positive/hormone receptor-positive metastatic breast cancer treated with palbociclib and trastuzumab: a correlative analysis of the PATRICIA (SOLTI 13-03) trial

E Ciruelos, P Villagrasa, L Paré, M Oliveira, L de la Peña, S Pernas, J Cortés, J Soberino, B Adamo, S Vazquez, N Martínez, A Perelló, B Bermejo, E Martínez, I Garau, M Melé, S Morales, P Galvan, T Pascual, P Nuciforo, X Gonzalez, A Prat
Journal: Cancer Research
Cancer Res (2018) 78 (4_Supplement): P5-20-19.
https://doi.org/10.1158/1538-7445.SABCS17-P5-20-19
Published: 15 February 2018
View articletitled, Abstract P5-20-19: PAM50 intrinsic subtype predicts survival outcome in HER2-positive/hormone receptor-positive metastatic breast cancer treated with palbociclib and trastuzumab: a correlative analysis of the PATRICIA (SOLTI 13-03) trial
Journal Articles

Abstract 281: Site specific risk factors for colorectal cancer

Samir Gupta, Ranier Bustamante, Ashley Earles, Maria E. Martinez, Karen Messer, Christina D. Williams, Andrew J. Gawron, Tonya Kaltenbach, Lin Liu
Journal: Cancer Research
Cancer Res (2017) 77 (13_Supplement): 281.
https://doi.org/10.1158/1538-7445.AM2017-281
Published: 01 July 2017
View articletitled, Abstract 281: Site specific risk factors for colorectal cancer
Journal Articles

Abstract P6-09-33: CASCADE study: Rapid survival decline per treatment line in metastatic breast cancer

J García, J De La Haba, S Servitja, A Santaballa, L De Paz, Y Plata, I Garau, J Florián, JI Chacón, P García, P Zamora, L Orcajo, J Rodríguez-Villanueva, B San José, E Martínez, MA Seguí
Journal: Cancer Research
Cancer Res (2017) 77 (4_Supplement): P6-09-33.
https://doi.org/10.1158/1538-7445.SABCS16-P6-09-33
Published: 15 February 2017
View articletitled, Abstract P6-09-33: CASCADE study: Rapid survival decline per treatment line in metastatic breast cancer
Journal Articles

Abstract 3468: High rates of informed consent for biospecimen sharing among hispanic women in a safety-net clinic

Jesse Nodora, Maria E. Martinez, Richard Schwab, Kristen Wells, Hyeon-eui Kim, Claudiu Farcas, Marcia Bouton, Ian Komenaka
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): 3468.
https://doi.org/10.1158/1538-7445.AM2016-3468
Published: 15 July 2016
View articletitled, Abstract 3468: High rates of informed consent for biospecimen sharing among hispanic women in a safety-net clinic
Journal Articles

Abstract P3-07-39: CASCADE study: Treatment and clinical outcomes of metastatic breast cancer by tumor immunophenotypes

P Zamora, S Servitja, A Santaballa, J García, L de Paz, Y Plata, I Garau, J Florian, I Chacón, J de la Haba, P García, E Artime, J Rodríguez-Villanueva, A Velasco, E Martínez, MA Segui
Journal: Cancer Research
Cancer Res (2016) 76 (4_Supplement): P3-07-39.
https://doi.org/10.1158/1538-7445.SABCS15-P3-07-39
Published: 15 February 2016
View articletitled, Abstract P3-07-39: CASCADE study: Treatment and clinical outcomes of metastatic breast cancer by tumor immunophenotypes
Journal Articles

Abstract P5-08-43: CASCADE study: Longer overall survival in the novo versus recidivant patients with locally advanced/metastatic breast cancer

S Servitja, P Zamora, A Santaballa, J García, L de Paz, Y Plata, I Garau, J Florian, I Chacón, J de la Haba, P García, B San José, J Rodríguez-Villanueva, L Orcajo, E Martínez, MA Segui
Journal: Cancer Research
Cancer Res (2016) 76 (4_Supplement): P5-08-43.
https://doi.org/10.1158/1538-7445.SABCS15-P5-08-43
Published: 15 February 2016
View articletitled, Abstract P5-08-43: CASCADE study: Longer overall survival in the novo versus recidivant patients with locally advanced/metastatic breast cancer
Journal Articles

Abstract P6-05-02: Intrinsic subtype and gene expression changes between primary and metastatic breast cancer

A Prat, E Martínez de Dueñas, P Galván, S Garcia, O Burgués, L Paré, S Antolín, R Martinello, I Blancas, B Adamo, Á Guerrero, M Muñoz, P Nuciforo, M Vidal, RM Pérez, JI Chacón, R Caballero, P Gascón, E Carrasco, F Rojo, CM Perou, J Cortés, V Adamo, J Albanell, A Lluch
Journal: Cancer Research
Cancer Res (2016) 76 (4_Supplement): P6-05-02.
https://doi.org/10.1158/1538-7445.SABCS15-P6-05-02
Published: 15 February 2016
View articletitled, Abstract P6-05-02: Intrinsic subtype and gene expression changes between primary and metastatic breast cancer
Journal Articles

Abstract 4024: Understanding the role of mitochondria in the progression from normal fibroblasts to DCIS associated fibroblasts

Ying-Hui Ko, Zhao Lin, Ubaldo E. Martinez Outschoorn
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 4024.
https://doi.org/10.1158/1538-7445.AM2015-4024
Published: 01 August 2015
View articletitled, Abstract 4024: Understanding the role of mitochondria in the progression from normal fibroblasts to DCIS associated fibroblasts